Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications Defeat Diabetes Foundation Drugs Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research    » Alternative Medicine    » Beta Cells    » Cause    » Cells    » Children    » Complications    » Control    » Cure    » Diagnosis    » Drugs    » Elderly    » Genes    » Immune Cells    » Inhaled Insulin    » Insulin    » Islet Cells    » Neuropathy    » Obesity    » Oral Insulin    » Other Diseases    » Pets    » Pre-Diabetes    » Prevention    » Research    » Retinopathy    » Risk Factors    » Stem Cells    » Technology    » Testing    » Transplants    » Treatments    » Trials    » Type 1    » Type 2 Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Research » Type 2

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Type 2s With A1c of 6.5% Benefit From Post-Meal Hyperglycemia Control With Nateglinide Posted: Friday, November 23, 2007

There has always been the question as to whether tighter control, treating to normal A1cs In type 2 diabetic patients is beneficial. This study showed that even in Type 2s with good glycemic control, additional reduction of postprandial hyperglycemia with nateglinide prevents the progression of atherosclerosis.

Intensive Diabetes Therapy Reduces Risk of Peripheral Artery Disease Posted: Friday, November 23, 2007

Compared to conventional treatment, intensive treatment of diabetes is associated with a reduced rate of peripheral arterial calcification, according to researchers.

Rosiglitazone to Stay on US Market With New Warnings About MI Posted: Friday, November 23, 2007

The FDA has decided to allow the diabetes drug rosiglitazone (Avandia, GlaxoSmithKline) to stay on the market with increased warnings about the risk of cardiovascular events, while further studies are conducted to investigate the issue. A myocardial infarction warning will be added to the black box warning.

More Black Children Dying From Diabetes Posted: Friday, November 23, 2007

Black children with diabetes face a death rate twice as high as that for white children, new U.S. government research shows.

Hemoglobin A1c Levels Effective Screening Test for Diabetes Posted: Friday, November 23, 2007

Measuring patients' glycosylated hemoglobin levels (A1C) could be used to screen for diabetes, according to California-based researchers. It was shown to be more effective then using fasting blood sugars.

High BP With Enlarged Heart Raises Diabetes Risk Posted: Friday, November 23, 2007

People who suffer from high blood pressure who are also found to have an abnormal enlargement of the heart's main pumping chamber -- the left ventricle -- are at an increased risk of developing diabetes, results of a study indicate.

ADA To Change Thinking On Low Carb Diets? Posted: Friday, November 23, 2007

Might it be a reality that the ADA might reduce its recommendations of getting most of our calories from carbohydrates? Could it be that they finally recognized that taking more medications rather then reducing the carbohydrates may not be the best treatment for patients with diabetes?

Fat Cells Play A Role in Insulin Secretion Posted: Friday, November 16, 2007

The body's fat cells help the pancreas do its job of secreting insulin, according to new research. This previously unrecognized process ultimately could lead to new methods to improve glucose metabolism in type 2 diabetic or insulin-resistant people.

Possible To Predict Type 2 in Early Childhood Posted: Friday, November 16, 2007

It may be possible to predict which kids are most likely to mature into adults with type 2 diabetes - and to nip that risk in the bud. A new study spotlights two key strategies.

Once Weekly Byetta Shows A 1.9% Drop in A1c Posted: Wednesday, November 07, 2007

Once-Weekly Exenatide showed statistical superiority in glucose control compared to BYETTA in head-to-head study.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.